IM Cannabis Corp. (IMCC) Stock Score, Valuation & Financial Research
IM Cannabis Corp. is in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 22/100.
Quick answer for IMCC
IM Cannabis Corp. currently has a Wall Street Score of 22/100. The stored market price is $1.75. Its financial score is 18/100. Its valuation score is 0/100. The latest WSS change is -2.3 points. These figures are a research snapshot, not a buy or sell recommendation.
What IM Cannabis Corp. does
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
IMCC financial snapshot
- Wall Street Score:
- 22/100
- Current price:
- $1.75
- Market capitalization:
- $1.1M
- Revenue:
- $29.9M
- Net income:
- $-11.4M
- Free cash flow:
- $3.4M
- Cash:
- $1.3M
- Total debt:
- $10.0M
- EPS:
- -18.84
- Financial score:
- 18/100
- Valuation score:
- 0/100
- Revenue score:
- 25/100
What stands out
- Reported year-over-year revenue growth is -0.2%.
- Free cash flow is $3.4M, showing positive cash generation.
- The balance sheet shows $1.3M of cash versus $10.0M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -2.3 points: IMCC decreased 2.3 points because Moat declined by 25 points, Buffett declined by 3.8 points.
- The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 18/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-13.
How to research IMCC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.